These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 2338124)
1. Eicosanoids as a new class of ocular hypotensive agents. 3. Prostaglandin A2-1-isopropyl ester is the most potent reported hypotensive agent on feline eyes. Bito LZ; Miranda OC; Tendler MR; Resul B Exp Eye Res; 1990 Apr; 50(4):419-28. PubMed ID: 2338124 [TBL] [Abstract][Full Text] [Related]
2. Eicosanoids as a new class of ocular hypotensive agents. 1. The apparent therapeutic advantages of derived prostaglandins of the A and B type as compared with primary prostaglandins of the E, F and D type. Bito LZ; Baroody RA; Miranda OC Exp Eye Res; 1987 Jun; 44(6):825-37. PubMed ID: 3653276 [TBL] [Abstract][Full Text] [Related]
3. Eicosanoids as a new class of ocular hypotensive agents. 2. Comparison of the apparent mechanism of the ocular hypotensive effects of A and F type prostaglandins. Hayashi M; Yablonski ME; Bito LZ Invest Ophthalmol Vis Sci; 1987 Oct; 28(10):1639-43. PubMed ID: 3654137 [TBL] [Abstract][Full Text] [Related]
4. Effects of prostaglandins F2 alpha, A2, and their esters in glaucomatous monkey eyes. Wang RF; Camras CB; Lee PY; Podos SM; Bito LZ Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2466-70. PubMed ID: 2243010 [TBL] [Abstract][Full Text] [Related]
5. Effect of topical prostaglandin PGA2, PGA2 isopropyl ester, and PGF2 alpha isopropyl ester on intraocular pressure in normotensive and glaucomatous canine eyes. Gum GG; Kingsbury S; Whitley RD; Garcia A; Gelatt KN J Ocul Pharmacol; 1991; 7(2):107-16. PubMed ID: 1919268 [TBL] [Abstract][Full Text] [Related]
6. Maintained reduction of intraocular pressure by prostaglandin F2 alpha-1-isopropyl ester applied in multiple doses in ocular hypertensive and glaucoma patients. Camras CB; Siebold EC; Lustgarten JS; Serle JB; Frisch SC; Podos SM; Bito LZ Ophthalmology; 1989 Sep; 96(9):1329-36; discussion 1336-7. PubMed ID: 2780003 [TBL] [Abstract][Full Text] [Related]
7. The ocular effects of prostaglandins and the therapeutic potential of a new PGF2 alpha analog, PhXA41 (latanoprost), for glaucoma management. Bito LZ; Stjernschantz J; Resul B; Miranda OC; Basu S J Lipid Mediat; 1993; 6(1-3):535-43. PubMed ID: 8358014 [TBL] [Abstract][Full Text] [Related]
8. Long-term maintenance of reduced intraocular pressure by daily or twice daily topical application of prostaglandins to cat or rhesus monkey eyes. Bito LZ; Draga A; Blanco J; Camras CB Invest Ophthalmol Vis Sci; 1983 Mar; 24(3):312-9. PubMed ID: 6572617 [TBL] [Abstract][Full Text] [Related]
9. PGF2 alpha/pilocarpine interactions on IOP and accommodation in monkeys. Millar JC; Kaufman PL Exp Eye Res; 1995 Dec; 61(6):677-83. PubMed ID: 8846839 [TBL] [Abstract][Full Text] [Related]
10. The ocular pharmacokinetics of eicosanoids and their derivatives. 1. Comparison of ocular eicosanoid penetration and distribution following the topical application of PGF2 alpha, PGF2 alpha-1-methyl ester, and PGF2 alpha-1-isopropyl ester. Bito LZ; Baroody RA Exp Eye Res; 1987 Feb; 44(2):217-26. PubMed ID: 3472899 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the ocular hypotensive efficacy of eicosanoids and related compounds. Bito LZ Exp Eye Res; 1984 Feb; 38(2):181-94. PubMed ID: 6370708 [TBL] [Abstract][Full Text] [Related]
12. Prostaglandin F2 alpha isopropyl ester versus iloprost phenacyl ester in rabbit and beagle eyes. Groeneboer MC; Hoyng PF; Kuizenga A Curr Eye Res; 1989 Feb; 8(2):131-8. PubMed ID: 2540937 [TBL] [Abstract][Full Text] [Related]
13. Effects of topically applied PGF2 alpha and its isopropylester on normal and glaucomatous human eyes. Alm A; Villumsen J Prog Clin Biol Res; 1989; 312():447-58. PubMed ID: 2678150 [TBL] [Abstract][Full Text] [Related]
14. Ocular effects of two different prostaglandin F2 alpha esters. A doublemasked cross-over study on normotensive eyes. Villumsen J; Alm A Acta Ophthalmol (Copenh); 1990 Jun; 68(3):341-3. PubMed ID: 2392914 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the hypotensive and other ocular effects of prostaglandins E2 and F2 alpha on cat and rhesus monkey eyes. Stern FA; Bito LZ Invest Ophthalmol Vis Sci; 1982 May; 22(5):588-98. PubMed ID: 7076404 [TBL] [Abstract][Full Text] [Related]
16. Initial clinical studies with prostaglandins and their analogues. Camras CB; Alm A Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S61-8. PubMed ID: 9154278 [TBL] [Abstract][Full Text] [Related]
17. The effect of prostaglandin F2 alpha on intraocular pressure in normotensive human subjects. Lee PY; Shao H; Xu LA; Qu CK Invest Ophthalmol Vis Sci; 1988 Oct; 29(10):1474-7. PubMed ID: 3170119 [TBL] [Abstract][Full Text] [Related]
18. Effects of topically applied prostaglandin F2 alpha tromethamine salt on glaucomatous human eyes. Erkiliç K; Ekinciler OF; Mirza GE; Doğan H; Cagil N Int J Clin Pharmacol Res; 1996; 16(2-3):51-5. PubMed ID: 9063756 [TBL] [Abstract][Full Text] [Related]
19. Reduction of intraocular pressure in normal and glaucomatous primate (Aotus trivirgatus) eyes by topically applied prostaglandin F2 alpha. Camras CB; Bito LZ Curr Eye Res; 1981; 1(4):205-9. PubMed ID: 6949676 [TBL] [Abstract][Full Text] [Related]
20. Effects of prostaglandin D2 and its analogues on intraocular pressure in rabbits. Goh Y; Nakajima M; Azuma I; Hayaishi O Jpn J Ophthalmol; 1988; 32(4):471-80. PubMed ID: 3236567 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]